Literature DB >> 3002572

Photodynamic therapy: cavitary photoillumination of malignant cerebral tumours using a laser coupled inflatable balloon.

P J Muller, B C Wilson.   

Abstract

Interest in photodynamic therapy of malignant brain tumours has been growing in recent years as intra-operative laser applications become more available. We have developed an inflatable balloon which can be coupled to an argon dye pump laser in order to deliver light to a brain tumour cavity created by the subtotal resection of tumour. Eight patients with primary malignant brain tumors have been treated with photodynamic therapy (PDT) using this device. The 8 patients tolerated the treatment well; morbidity attributable to the PDT was acceptably low.

Entities:  

Mesh:

Year:  1985        PMID: 3002572     DOI: 10.1017/s0317167100035563

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  4 in total

1.  An indwelling brachytherapy balloon catheter: potential use as an intracranial light applicator for photodynamic therapy.

Authors:  H Hirschberg; S Madsen; K Lote; T Pham; B Tromberg
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids.

Authors:  Henry Hirschberg; Chung-Ho Sun; Bruce J Tromberg; Alvin T Yeh; Steen J Madsen
Journal:  J Neurooncol       Date:  2004-12       Impact factor: 4.130

3.  ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial.

Authors:  M Sam Eljamel; Carol Goodman; Harry Moseley
Journal:  Lasers Med Sci       Date:  2007-10-10       Impact factor: 3.161

4.  Interrelation between Spectral Online Monitoring and Postoperative T1-Weighted MRI in Interstitial Photodynamic Therapy of Malignant Gliomas.

Authors:  Maximilian Aumiller; Christian Heckl; Stefanie Quach; Herbert Stepp; Birgit Ertl-Wagner; Ronald Sroka; Niklas Thon; Adrian Rühm
Journal:  Cancers (Basel)       Date:  2021-12-27       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.